McKesson Corporation

NYSE:MCK Stock Report

Market Cap: US$86.8b

McKesson Past Earnings Performance

Past criteria checks 1/6

McKesson has been growing earnings at an average annual rate of 40.8%, while the Healthcare industry saw earnings growing at 2.1% annually. Revenues have been growing at an average rate of 8.6% per year.

Key information

40.79%

Earnings growth rate

43.29%

EPS growth rate

Healthcare Industry Growth8.50%
Revenue growth rate8.60%
Return on equityn/a
Net Margin0.92%
Last Earnings Update31 Mar 2025

Recent past performance updates

McKesson's (NYSE:MCK) Soft Earnings Don't Show The Whole Picture

Nov 14
McKesson's (NYSE:MCK) Soft Earnings Don't Show The Whole Picture

Recent updates

McKesson: Spin-Off Of Medical-Surgical Solutions Is A Positive, Strong Buy

May 09

McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025

Mar 25

McKesson Seems Cheap, But Risks Linger

Jan 21

Investors Still Waiting For A Pull Back In McKesson Corporation (NYSE:MCK)

Dec 19
Investors Still Waiting For A Pull Back In McKesson Corporation (NYSE:MCK)

McKesson's (NYSE:MCK) Soft Earnings Don't Show The Whole Picture

Nov 14
McKesson's (NYSE:MCK) Soft Earnings Don't Show The Whole Picture

McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network

Nov 09

McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff

Oct 09

McKesson: The Correction Is Not Over

Sep 10

McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

Aug 22
McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

McKesson Corporation: An Interesting Health Giant With A Hidden Gem

Jul 04

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

Feb 19

McKesson: Why The Company Is Too Richly Valued

Jan 19

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Nov 08

McKesson: Still Trading For A Huge Discount

Sep 06

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

Jun 28

Revenue & Expenses Breakdown

How McKesson makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:MCK Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 25359,0513,2957,1810
31 Dec 24344,5832,8268,2030
30 Sep 24330,1872,5368,5520
30 Jun 24313,7512,9598,1130
31 Mar 24308,9513,0028,0100
31 Dec 23301,5062,9987,8090
30 Sep 23291,0983,4877,9720
30 Jun 23284,0403,7557,8810
31 Mar 23276,7113,5637,9140
31 Dec 22273,9033,1468,2580
30 Sep 22272,0272,0618,4380
30 Jun 22268,4461,3968,7020
31 Mar 22263,9661,1198,9370
31 Dec 21257,0061,4158,9180
30 Sep 21250,991-4,8048,9260
30 Jun 21245,223-4,4948,9190
31 Mar 21238,228-4,5388,7910
31 Dec 20237,621-4,1898,6960
30 Sep 20234,1942,2288,8750
30 Jun 20231,0029228,8640
31 Mar 20231,0519068,9070
31 Dec 19224,945-9059,64171
30 Sep 19221,981-6269,16071
30 Jun 19217,4406018,64271
31 Mar 19214,319338,4370
31 Dec 18213,518-3198,362125
30 Sep 18210,9271138,197125
30 Jun 18209,913-3848,300125
31 Mar 18208,357628,138125
31 Dec 17205,4424,8057,464341
30 Sep 17201,9554,5397,503341
30 Jun 17199,8514,8467,317341
31 Mar 17198,5335,1947,447341
31 Dec 16196,4982,0517,149392
30 Sep 16194,2672,0447,264392
30 Jun 16193,0712,3597,283392
31 Mar 16190,8842,2907,379392
31 Dec 15189,1312,2377,573392
30 Sep 15187,7162,0907,342392
30 Jun 15183,1151,9507,781392
31 Mar 15179,0451,7757,901392
31 Dec 14171,9521,7807,323457
30 Sep 14159,8041,4626,932457
30 Jun 14148,6291,4026,143457

Quality Earnings: MCK has a large one-off loss of $1.2B impacting its last 12 months of financial results to 31st March, 2025.

Growing Profit Margin: MCK's current net profit margins (0.9%) are lower than last year (1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MCK's earnings have grown significantly by 40.8% per year over the past 5 years.

Accelerating Growth: MCK's earnings growth over the past year (9.8%) is below its 5-year average (40.8% per year).

Earnings vs Industry: MCK earnings growth over the past year (9.8%) did not outperform the Healthcare industry 18.4%.

Return on Equity

High ROE: MCK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 18:53
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

McKesson Corporation is covered by 39 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Gregory BolanAvondale Partners
Eric ColdwellBaird